Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/25 20:14 | 1/6/25 | KALA | Health | Drug | Pharmaceutical Preparations | Kharabi Darius | MA | O | CHIEF BU | 4 | S.d | -51 | 5.76 | 0 | -9 | 68 | D | |||||||||||||||
1/7/25 20:14 | 1/6/25 | KALA | Health | Drug | Pharmaceutical Preparations | Bazemore Todd | MA | O | SEE REMA | 4 | S.d | -60 | 5.87 | 0 | -10 | 88 | D | |||||||||||||||
1/7/25 20:13 | 1/6/25 | KALA | Health | Drug | Pharmaceutical Preparations | Brazzell Romulus K | MA | O | SEE REMA | 4 | S.d | -68 | 5.87 | 0 | -12 | 92 | D | |||||||||||||||
1/7/25 20:12 | 1/6/25 | KALA | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | DO | CEO | 4 | S.d | -192 | 5.83 | 0 | -33 | 286 | D | |||||||||||||||
1/7/25 20:12 | 1/6/25 | KALA | Health | Drug | Pharmaceutical Preparations | Reumuth Mary | MA | O | CFO | 4 | S.d | -52 | 5.85 | 0 | -9 | 69 | D | |||||||||||||||
1/5/24 16:07 | 1/4/24 | KALA | Health | Drug | Pharmaceutical Preparations | Trachtenberg Eric | MA | O | SEE REMA | 1 | S.d | -8 | 6.74 | 0 | -1 | 68 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |